Drug Name,Disease Group,Generic Name/API,Indication Name,Route of Administration
Abilify Maintena,Psychiatry,aripiprazole,Schizophrenia,Intramuscular (IM)
Abilify Maintena,Psychiatry,aripiprazole,Bipolar Disorder,Intramuscular (IM)
Adakveo,Hematology,crizanlizumab-tmca,Sickle Cell Anemia,Intravenous (IV)
Aimovig,Neurology,erenumab-aooe,Migraine and Other Headaches,Subcutaneous (SQ)
Aimovig,Endocrine,erenumab-aooe,Menopause (including Hormone Replacement Therapy [HRT]),Subcutaneous (SQ)
Allegra,Allergy,fexofenadine hydrochloride,Allergic Rhinitis,Oral (PO)
Allegra,Allergy,fexofenadine hydrochloride,Urticaria,Oral (PO)
Allegra,Allergy,fexofenadine hydrochloride,Atopic Dermatitis (Eczema),Oral (PO)
Apokyn,Neurology,apomorphine hydrochloride,Parkinson's Disease (PD),Subcutaneous (SQ)
Arcapta Neohaler,Respiratory,indacaterol maleate,Asthma,Inhaled
Arcapta Neohaler,Respiratory,indacaterol maleate,Chronic Obstructive Pulmonary Disease (COPD),Inhaled
Atacand,Cardiovascular,candesartan cilexetil,Hypertension (Systemic),Oral (PO)
Atacand,Cardiovascular,candesartan cilexetil,Congestive Heart Failure (CHF) and Cardiomyopathies,Oral (PO)
Atacand,Ophthalmology,candesartan cilexetil,Diabetic Retinopathy (Ophthalmology),Oral (PO)
Avapro,Cardiovascular,irbesartan,Hypertension (Systemic),Oral (PO)
Avapro,Endocrine,irbesartan,Diabetic Nephropathy,Oral (PO)
Avapro,Cardiovascular,irbesartan,Atrial Fibrillation/Flutter,Oral (PO)
Avonex,Autoimmune/immunology,interferon beta-1a,Ulcerative Colitis (UC),Intramuscular (IM)
Avonex,Neurology,interferon beta-1a,Multiple Sclerosis (MS),Intramuscular (IM)
Baqsimi,Endocrine,glucagon,Hyperinsulinemia/Hypoglycemia,"Intramuscular (IM), Intranasal"
Belsomra,Neurology,suvorexant,Insomnia,Oral (PO)
Bemfola,Obstetrics/Gynecology,follitropin alfa,Reproductive Disorder,Subcutaneous (SQ)
Betaseron,Neurology,interferon beta-1b,Multiple Sclerosis (MS),Subcutaneous (SQ)
Blincyto,Oncology,blinatumomab,Indolent Non-Hodgkin's Lymphoma (Including Follicular Lymphoma) - NHL,Intravenous (IV)
Blincyto,Oncology,blinatumomab,Mantle Cell Lymphoma - NHL,Intravenous (IV)
Blincyto,Oncology,blinatumomab,Diffuse Large B-Cell Lymphoma (DLBCL) - NHL,Intravenous (IV)
Blincyto,Oncology,blinatumomab,Waldenstrom Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) - NHL,Intravenous (IV)
Blincyto,Oncology,blinatumomab,Acute Lymphoblastic Leukemia (ALL),Intravenous (IV)
Blincyto,Oncology,blinatumomab,Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL,Intravenous (IV)
Brilinta,Cardiovascular,ticagrelor,Peripheral Arterial Disease (PAD),Oral (PO)
Brilinta,Cardiovascular,ticagrelor,Acute Coronary Syndrome (ACS),Oral (PO)
Brilinta,Hematology,ticagrelor,Sickle Cell Anemia,Oral (PO)
Brilinta,Neurology,ticagrelor,Ischemic Stroke,Oral (PO)
Brilinta,Cardiovascular,ticagrelor,Coronary Artery Disease,Oral (PO)
Brilinta,Cardiovascular,ticagrelor,Percutaneous Coronary Interventions (PCIs) for Stable Angina,Oral (PO)
Brixadi,Neurology,buprenorphine,Chronic Low Back Pain (CLBP),Subcutaneous (SQ)
Brixadi,Psychiatry,buprenorphine,Substance Use Disorder,Subcutaneous (SQ)
Bydureon,Endocrine,exenatide,"Diabetes Mellitus, Type II",Subcutaneous (SQ)
Bydureon,Metabolic,exenatide,Obesity,Subcutaneous (SQ)
Bydureon,Neurology,exenatide,Parkinson's Disease (PD),Subcutaneous (SQ)
Byetta,Endocrine,exenatide,"Diabetes Mellitus, Type II",Subcutaneous (SQ)
Byetta,Endocrine,exenatide,"Diabetes Mellitus, Type I",Subcutaneous (SQ)
Byetta,Infectious Disease,exenatide,Sepsis and Septic Shock,Subcutaneous (SQ)
Byetta,Metabolic,exenatide,Obesity,Subcutaneous (SQ)
Caplyta,Psychiatry,lumateperone,Schizophrenia,"Intravenous (IV), Oral (PO)"
Caplyta,Neurology,lumateperone,Insomnia,"Intravenous (IV), Oral (PO)"
Caplyta,Psychiatry,lumateperone,Major Depressive Disorder (MDD),"Intravenous (IV), Oral (PO)"
Caplyta,Psychiatry,lumateperone,Bipolar Disorder,"Intravenous (IV), Oral (PO)"
Caplyta,Neurology,lumateperone,Alzheimer's Disease (AD),"Intravenous (IV), Oral (PO)"
Clarinex,Allergy,desloratadine,Pruritus,Oral (PO)
Clarinex,Allergy,desloratadine,Allergic Rhinitis,Oral (PO)
Clarinex,Allergy,desloratadine,Urticaria,Oral (PO)
Cozaar,Cardiovascular,losartan,Hypertension (Systemic),Oral (PO)
Cozaar,Cardiovascular,losartan,Congestive Heart Failure (CHF) and Cardiomyopathies,Oral (PO)
Cozaar,Endocrine,losartan,Diabetic Nephropathy,Oral (PO)
Diovan,Cardiovascular,valsartan,Hypertension (Systemic),Oral (PO)
Diovan,Cardiovascular,valsartan,Congestive Heart Failure (CHF) and Cardiomyopathies,Oral (PO)
Diovan,Endocrine,valsartan,"Diabetes Mellitus, Type II",Oral (PO)
Diovan,Cardiovascular,valsartan,Cardiovascular Disease,Oral (PO)
Eligard,Oncology,leuprolide acetate,Prostate Cancer,Subcutaneous (SQ)
Eligard,Endocrine,leuprolide acetate,Endocrine Disorder,Subcutaneous (SQ)
Emend (Oral),Not Specified,aprepitant,Emesis,Oral (PO)
Emend (Oral),Oncology,aprepitant,Chemotherapy Induced Nausea and Vomiting (CINV),Oral (PO)
Emend (Oral),Allergy,aprepitant,Pruritus,Oral (PO)
Enspryng,Autoimmune/immunology,satralizumab-mwge,Rheumatoid Arthritis (RA),Subcutaneous (SQ)
Enspryng,Autoimmune/immunology,satralizumab-mwge,"Neuromyelitis Optica (Devic's Syndrome, NMO)",Subcutaneous (SQ)
Entyvio,Autoimmune/immunology,vedolizumab,Bone Marrow and Stem Cell Transplant - Graft vs. Host Disease (GVHD) Prophylaxis,"Intravenous (IV), Subcutaneous (SQ)"
Entyvio,Oncology,vedolizumab,Melanoma,"Intravenous (IV), Subcutaneous (SQ)"
Entyvio,Autoimmune/immunology,vedolizumab,Primary Sclerosing Cholangitis (PSC),"Intravenous (IV), Subcutaneous (SQ)"
Entyvio,Autoimmune/immunology,vedolizumab,Crohn's Disease,"Intravenous (IV), Subcutaneous (SQ)"
Entyvio,Autoimmune/immunology,vedolizumab,Ulcerative Colitis (UC),"Intravenous (IV), Subcutaneous (SQ)"
Epidiolex,Neurology,cannabidiol,Infantile Spasms (West Syndrome; Epilepsy),Oral (PO)
Epidiolex,Neurology,cannabidiol,Rett Syndrome,Oral (PO)
Epidiolex,Oncology,cannabidiol,Tuberous Sclerosis Complex (TSC),Oral (PO)
Epidiolex,Neurology,cannabidiol,Lennox-Gastaut Syndrome (LGS; Epilepsy),Oral (PO)
Epidiolex,Neurology,cannabidiol,Dravet Syndrome (Epilepsy),Oral (PO)
Epogen,Hematology,epoetin alfa,"Anemia Due to Chronic Renal Failure, Dialysis-Dependent","Intravenous (IV), Subcutaneous (SQ)"
Epogen,Cardiovascular,epoetin alfa,Acute Coronary Syndrome (ACS),"Intravenous (IV), Subcutaneous (SQ)"
Epogin,Hematology,epoetin beta,Anemia Due to Oncology Treatment,"Intravenous (IV), Subcutaneous (SQ)"
Epogin,Hematology,epoetin beta,Anemia,"Intravenous (IV), Subcutaneous (SQ)"
Epogin,Hematology,epoetin beta,"Anemia Due to Chronic Renal Failure, Dialysis-Dependent","Intravenous (IV), Subcutaneous (SQ)"
Erivedge,Oncology,vismodegib,Skin Cancer - Basal Cell Carcinoma (BCC),Oral (PO)
Erivedge,Oncology,vismodegib,Ovarian Cancer,Oral (PO)
Erivedge,Oncology,vismodegib,Colorectal Cancer (CRC),Oral (PO)
Erivedge,Oncology,vismodegib,Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM)),Oral (PO)
Erivedge,Oncology,vismodegib,Bone Cancer,Oral (PO)
Erivedge,Oncology,vismodegib,Sarcoma,Oral (PO)
Erivedge,Oncology,vismodegib,Acute Myelogenous Leukemia (AML),Oral (PO)
Erivedge,Oncology,vismodegib,Myelodysplastic Syndrome (MDS),Oral (PO)
Erivedge,Oncology,vismodegib,Multiple Myeloma (MM),Oral (PO)
Erivedge,Oncology,vismodegib,Gastric Cancer,Oral (PO)
Erivedge,Oncology,vismodegib,Breast Cancer,Oral (PO)
Erivedge,Oncology,vismodegib,Small Cell Lung Cancer (SCLC),Oral (PO)
Erivedge,Oncology,vismodegib,Prostate Cancer,Oral (PO)
Erivedge,Respiratory,vismodegib,Idiopathic Pulmonary Fibrosis (IPF),Oral (PO)
Erivedge,Oncology,vismodegib,Myelofibrosis (MF),Oral (PO)
Erivedge,Oncology,vismodegib,Cancer,Oral (PO)
Fanapt,Psychiatry,iloperidone,Major Depressive Disorder (MDD),Oral (PO)
Fanapt,Psychiatry,iloperidone,Schizophrenia,Oral (PO)
Fanapt,Psychiatry,iloperidone,Bipolar Disorder,Oral (PO)
Fasenra,Respiratory,benralizumab,Asthma,Subcutaneous (SQ)
Fasenra,Respiratory,benralizumab,Chronic Obstructive Pulmonary Disease (COPD),Subcutaneous (SQ)
Fasenra,Oncology,benralizumab,Hypereosinophilic Syndrome (HES),Subcutaneous (SQ)
Fasenra,Autoimmune/immunology,benralizumab,Esophagitis,Subcutaneous (SQ)
Fasenra,Autoimmune/immunology,benralizumab,Antineutrophil Cytoplasmic Antibodies (ANCA) Associated Vasculitis,Subcutaneous (SQ)
Fasenra,Allergy,benralizumab,Nasal Polyposis,Subcutaneous (SQ)
Fasenra,Allergy,benralizumab,Atopic Dermatitis (Eczema),Subcutaneous (SQ)
Fasenra,Autoimmune/immunology,benralizumab,Bullous Pemphigoid,Subcutaneous (SQ)
Firazyr,Infectious Disease,icatibant,COVID-19 Treatment,Subcutaneous (SQ)
Firazyr,Neurology,icatibant,Arthritis Pain,Subcutaneous (SQ)
Firazyr,Cardiovascular,icatibant,Drug-induced Angioedema,Subcutaneous (SQ)
Firazyr,Autoimmune/immunology,icatibant,Hereditary Angioedema (HAE),Subcutaneous (SQ)
Flomax,Urology,tamsulosin hydrochloride,Benign Prostatic Hyperplasia (BPH),Oral (PO)
Forteo,Endocrine,teriparatide recombinant human,Osteoporosis / Osteopenia,Subcutaneous (SQ)
Gattex,Autoimmune/immunology,teduglutide,Crohn's Disease,Subcutaneous (SQ)
Gattex,Gastroenterology (Non Inflammatory Bowel Disease),teduglutide,Short Bowel Syndrome (SBS),Subcutaneous (SQ)
Gattex,Gastroenterology (Non Inflammatory Bowel Disease),teduglutide,Necrotizing Enterocolitis (NEC),Subcutaneous (SQ)
Genotropin,Endocrine,somatropin recombinant,Short Stature / Growth Hormone Deficiency,Subcutaneous (SQ)
Genotropin,Endocrine,somatropin recombinant,Turner Syndrome,Subcutaneous (SQ)
Genotropin,Endocrine,somatropin recombinant,Prader-Willi Syndrome,Subcutaneous (SQ)
Gilenya,Neurology,fingolimod hydrochloride,Multiple Sclerosis (MS),Oral (PO)
Gilenya,Autoimmune/immunology,fingolimod hydrochloride,Kidney Transplant Rejection,Oral (PO)
Gilenya,Neurology,fingolimod hydrochloride,Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),Oral (PO)
Gilenya,Neurology,fingolimod hydrochloride,Amyotrophic Lateral Sclerosis (ALS),Oral (PO)
Gonal-F,Obstetrics/Gynecology,follitropin alfa,Reproductive Disorder,Subcutaneous (SQ)
Humatrope,Endocrine,somatropin recombinant,Turner Syndrome,Subcutaneous (SQ)
Humatrope,Endocrine,somatropin recombinant,Short Stature / Growth Hormone Deficiency,Subcutaneous (SQ)
Imitrex,Neurology,sumatriptan succinate,Migraine and Other Headaches,"Intranasal, Oral (PO), Subcutaneous (SQ)"
Incruse Ellipta,Respiratory,umeclidinium bromide,Asthma,"Inhaled, Topical"
Incruse Ellipta,Respiratory,umeclidinium bromide,Chronic Obstructive Pulmonary Disease (COPD),"Inhaled, Topical"
Incruse Ellipta,Dermatology,umeclidinium bromide,Dermatology,"Inhaled, Topical"
Intuniv Extended Release,Neurology,guanfacine hydrochloride,Tourette's Syndrome,Oral (PO)
Intuniv Extended Release,Psychiatry,guanfacine hydrochloride,Attention Deficit Hyperactivity Disorder (ADHD),Oral (PO)
Jynarque,Renal,tolvaptan,Polycystic Kidney Disease,Oral (PO)
Keytruda,Oncology,pembrolizumab,Thymic Carcinoma,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Skin Cancer - Squamous Cell Carcinoma (SCC) ,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Pancreatic Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Thyroid Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Neuroendocrine Tumors (NET),Intravenous (IV)
Keytruda,Infectious Disease,pembrolizumab,Progressive Multifocal Leukoencephalopathy (PML),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Myelodysplastic Syndrome (MDS),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Indolent Non-Hodgkin's Lymphoma (Including Follicular Lymphoma) - NHL,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Hematologic Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Diffuse Large B-Cell Lymphoma (DLBCL) - NHL,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Sarcoma,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Cervical Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM)),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Mesothelioma,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Ovarian Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Small Cell Lung Cancer (SCLC),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Merkel Cell Carcinoma,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Anal Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Biliary Tract Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Esophageal Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Multiple Myeloma (MM),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Colorectal Cancer (CRC),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Renal Cell Cancer (RCC),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Prostate Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Gastric Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Bladder Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Head and Neck Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Breast Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Acute Myelogenous Leukemia (AML),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Uterine (Endometrial) Cancer,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Non-Small Cell Lung Cancer (NSCLC),Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Solid Tumors,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Hodgkin's Lymphoma,Intravenous (IV)
Keytruda,Oncology,pembrolizumab,Melanoma,Intravenous (IV)
Kineret,Endocrine,anakinra,"Diabetes Mellitus, Type I",Subcutaneous (SQ)
Kineret,Autoimmune/immunology,anakinra,Cryopyrin (CIAS1)-Associated Periodic Syndromes (CAPS),Subcutaneous (SQ)
Kineret,Rheumatology (Non Autoimmune),anakinra,Osteoarthritis and Osteoarthritis Pain,Subcutaneous (SQ)
Kineret,Oncology,anakinra,Cancer,Subcutaneous (SQ)
Kineret,Autoimmune/immunology,anakinra,Axial Spondyloarthritis,Subcutaneous (SQ)
Kineret,Autoimmune/immunology,anakinra,Juvenile Rheumatoid Arthritis,Subcutaneous (SQ)
Kineret,Autoimmune/immunology,anakinra,Rheumatoid Arthritis (RA),Subcutaneous (SQ)
Kineret,Infectious Disease,anakinra,COVID-19 Treatment,Subcutaneous (SQ)
Kineret,Autoimmune/immunology,anakinra,Inflammatory Disorders,Subcutaneous (SQ)
Kineret,Autoimmune/immunology,anakinra,Gout,Subcutaneous (SQ)
Lemtrada,Neurology,alemtuzumab,Multiple Sclerosis (MS),Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Skin Cancer - Squamous Cell Carcinoma (SCC) ,Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Solid Tumors,Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Skin Cancer - Basal Cell Carcinoma (BCC),Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM)),Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Renal Cell Cancer (RCC),Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Hematologic Cancer,Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Melanoma,Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Non-Small Cell Lung Cancer (NSCLC),Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Hodgkin's Lymphoma,Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Cervical Cancer,Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Prostate Cancer,Intravenous (IV)
Libtayo,Oncology,cemiplimab-rwlc,Head and Neck Cancer,Intravenous (IV)
Lumigan,Ophthalmology,bimatoprost,Glaucoma / Ocular Hypertension (Ophthalmology),Topical
Lupron,Endocrine,leuprolide acetate,Endocrine Disorder,Subcutaneous (SQ)
Lupron,Hematology,leuprolide acetate,Anemia,Subcutaneous (SQ)
Lupron,Obstetrics/Gynecology,leuprolide acetate,Endometriosis,Subcutaneous (SQ)
Lupron,Oncology,leuprolide acetate,Breast Cancer,Subcutaneous (SQ)
Lupron,Oncology,leuprolide acetate,Prostate Cancer,Subcutaneous (SQ)
Lupron,Obstetrics/Gynecology,leuprolide acetate,Uterine Fibroids,Subcutaneous (SQ)
Lupron,Metabolic,leuprolide acetate,"Spinal Bulbar Muscular Atrophy (SBMA, Kennedy's Disease, X-linked spinal muscular atrophy type 1)",Subcutaneous (SQ)
Lutathera,Oncology,lutetium Lu 177 dotatate,Small Cell Lung Cancer (SCLC),Intravenous (IV)
Lutathera,Oncology,lutetium Lu 177 dotatate,Neuroendocrine Tumors (NET),Intravenous (IV)
Mayzent,Neurology,siponimod,Multiple Sclerosis (MS),Oral (PO)
Mayzent,Autoimmune/immunology,siponimod,Dermatomyositis,Oral (PO)
Mayzent,Neurology,siponimod,Hemorrhagic Stroke / Intracerebral Hemorrhage (ICH),Oral (PO)
Mircera,Hematology,methoxy polyethylene glycol-epoetin beta,"Anemia Due to Chronic Renal Failure, Dialysis-Dependent","Intravenous (IV), Subcutaneous (SQ)"
Mircera,Hematology,methoxy polyethylene glycol-epoetin beta,"Anemia Due to Chronic Renal Failure, Dialysis-Independent","Intravenous (IV), Subcutaneous (SQ)"
Mircera,Hematology,methoxy polyethylene glycol-epoetin beta,Anemia Due to Oncology Treatment,"Intravenous (IV), Subcutaneous (SQ)"
Motegrity,Gastroenterology (Non Inflammatory Bowel Disease),prucalopride,Chronic Idiopathic Constipation,Oral (PO)
Motegrity,Gastroenterology (Non Inflammatory Bowel Disease),prucalopride,Opioid Induced Constipation (OIC),Oral (PO)
Motegrity,Gastroenterology (Non Inflammatory Bowel Disease),prucalopride,Postoperative Ileus,Oral (PO)
Mozobil,Oncology,plerixafor,Acute Myelogenous Leukemia (AML),Subcutaneous (SQ)
Mozobil,Oncology,plerixafor,Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL,Subcutaneous (SQ)
Mozobil,Oncology,plerixafor,Bone Marrow Transplant and Stem Cell Transplant,Subcutaneous (SQ)
Mozobil,Oncology,plerixafor,Head and Neck Cancer,Subcutaneous (SQ)
Mozobil,Oncology,plerixafor,Pancreatic Cancer,Subcutaneous (SQ)
Myrbetriq,Cardiovascular,mirabegron,Congestive Heart Failure (CHF) and Cardiomyopathies,Oral (PO)
Myrbetriq,Urology,mirabegron,Overactive Bladder (OAB),Oral (PO)
Neulasta,Hematology,pegfilgrastim,Neutropenia / Leukopenia,Subcutaneous (SQ)
Neulasta,Autoimmune/immunology,pegfilgrastim,Bone Marrow and Stem Cell Transplant - Graft vs. Host Disease (GVHD) Prophylaxis,Subcutaneous (SQ)
Neupogen,Not Specified,filgrastim,Acute Radiation Syndrome (ARS),"Intravenous (IV), Subcutaneous (SQ)"
Neupogen,Oncology,filgrastim,Bone Marrow Transplant and Stem Cell Transplant,"Intravenous (IV), Subcutaneous (SQ)"
Neupogen,Hematology,filgrastim,Neutropenia / Leukopenia,"Intravenous (IV), Subcutaneous (SQ)"
Neupogen,Cardiovascular,filgrastim,Peripheral Arterial Disease (PAD),"Intravenous (IV), Subcutaneous (SQ)"
Neupogen,Oncology,filgrastim,Non-Hodgkin's Lymphoma (NHL),"Intravenous (IV), Subcutaneous (SQ)"
Neupogen,Oncology,filgrastim,Acute Myelogenous Leukemia (AML),"Intravenous (IV), Subcutaneous (SQ)"
Neupro,Neurology,rotigotine,Fibromyalgia,Transdermal
Neupro,Neurology,rotigotine,Parkinson's Disease (PD),Transdermal
Neupro,Neurology,rotigotine,Restless Leg Syndrome (RLS),Transdermal
Norditropin,Metabolic,somatropin,Cachexia / Weight Loss,Intravenous (IV)
Norditropin,Endocrine,somatropin,Short Stature / Growth Hormone Deficiency,Intravenous (IV)
Norditropin,Endocrine,somatropin,Prader-Willi Syndrome,Intravenous (IV)
Nourianz,Neurology,istradefylline,Parkinson's Disease (PD),Oral (PO)
Nourianz,Neurology,istradefylline,Restless Leg Syndrome (RLS),Oral (PO)
Nplate,Hematology,romiplostim,Thrombocytopenia,Subcutaneous (SQ)
Nplate,Autoimmune/immunology,romiplostim,Immune Thrombocytopenic Purpura (ITP),Subcutaneous (SQ)
Nplate,Hematology,romiplostim,Aplastic Anemia,Subcutaneous (SQ)
Nplate,Not Specified,romiplostim,Acute Radiation Syndrome (ARS),Subcutaneous (SQ)
Nuplazid,Neurology,pimavanserin,Dementia,Oral (PO)
Nuplazid,Psychiatry,pimavanserin,Major Depressive Disorder (MDD),Oral (PO)
Nuplazid,Neurology,pimavanserin,Parkinson's Disease (PD),Oral (PO)
Nuplazid,Psychiatry,pimavanserin,Schizophrenia,Oral (PO)
Nuplazid,Neurology,pimavanserin,Insomnia,Oral (PO)
Nuplazid,Neurology,pimavanserin,Alzheimer's Disease (AD),Oral (PO)
Nurtec ODT,Neurology,rimegepant,Migraine and Other Headaches,Oral (PO)
Nurtec ODT,Autoimmune/immunology,rimegepant,Psoriasis,Oral (PO)
Opdivo,Oncology,nivolumab,Merkel Cell Carcinoma,Intravenous (IV)
Opdivo,Oncology,nivolumab,Biliary Tract Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Anal Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Breast Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Mesothelioma,Intravenous (IV)
Opdivo,Oncology,nivolumab,Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Testicular Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Primary Central Nervous System Lymphoma (PCNSL) - NHL,Intravenous (IV)
Opdivo,Infectious Disease,nivolumab,Sepsis and Septic Shock,Intravenous (IV)
Opdivo,Oncology,nivolumab,Multiple Myeloma (MM),Intravenous (IV)
Opdivo,Oncology,nivolumab,Cervical Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Myelodysplastic Syndrome (MDS),Intravenous (IV)
Opdivo,Oncology,nivolumab,Acute Myelogenous Leukemia (AML),Intravenous (IV)
Opdivo,Oncology,nivolumab,Diffuse Large B-Cell Lymphoma (DLBCL) - NHL,Intravenous (IV)
Opdivo,Oncology,nivolumab,Sarcoma,Intravenous (IV)
Opdivo,Oncology,nivolumab,Indolent Non-Hodgkin's Lymphoma (Including Follicular Lymphoma) - NHL,Intravenous (IV)
Opdivo,Oncology,nivolumab,Small Cell Lung Cancer (SCLC),Intravenous (IV)
Opdivo,Oncology,nivolumab,Bladder Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Ovarian Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Non-Hodgkin's Lymphoma (NHL),Intravenous (IV)
Opdivo,Oncology,nivolumab,Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM)),Intravenous (IV)
Opdivo,Oncology,nivolumab,Hematologic Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Pancreatic Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Gastric Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Head and Neck Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Esophageal Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Hodgkin's Lymphoma,Intravenous (IV)
Opdivo,Oncology,nivolumab,Melanoma,Intravenous (IV)
Opdivo,Infectious Disease,nivolumab,Hepatitis C (HCV) (Antiviral),Intravenous (IV)
Opdivo,Oncology,nivolumab,Colorectal Cancer (CRC),Intravenous (IV)
Opdivo,Oncology,nivolumab,Prostate Cancer,Intravenous (IV)
Opdivo,Oncology,nivolumab,Solid Tumors,Intravenous (IV)
Opdivo,Oncology,nivolumab,Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases),Intravenous (IV)
Opdivo,Oncology,nivolumab,Non-Small Cell Lung Cancer (NSCLC),Intravenous (IV)
Opdivo,Oncology,nivolumab,Renal Cell Cancer (RCC),Intravenous (IV)
Opsumit,Cardiovascular,macitentan,Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH),Oral (PO)
Opsumit,Oncology,macitentan,Brain Cancer (Malignant Glioma; AA and glioblastoma (GBM)),Oral (PO)
Opsumit,Autoimmune/immunology,macitentan,Scleroderma,Oral (PO)
Opsumit,Respiratory,macitentan,Idiopathic Pulmonary Fibrosis (IPF),Oral (PO)
Opsumit,Cardiovascular,macitentan,Congestive Heart Failure (CHF) and Cardiomyopathies,Oral (PO)
Orilissa,Endocrine,elagolix,Endocrine Disorder,Oral (PO)
Orilissa,Obstetrics/Gynecology,elagolix,Uterine Fibroids,Oral (PO)
Orilissa,Obstetrics/Gynecology,elagolix,Endometriosis,Oral (PO)
Orilissa,Urology,elagolix,Benign Prostatic Hyperplasia (BPH),Oral (PO)
Ozempic,Endocrine,semaglutide,"Diabetes Mellitus, Type II",Subcutaneous (SQ)
Ozempic,Cardiovascular,semaglutide,Cardiovascular Disease,Subcutaneous (SQ)
Ozempic,Endocrine,semaglutide,Non-Alcoholic Steatohepatitis (NASH),Subcutaneous (SQ)
Ozempic,Endocrine,semaglutide,Diabetic Nephropathy,Subcutaneous (SQ)
Ozempic,Ophthalmology,semaglutide,Diabetic Retinopathy (Ophthalmology),Subcutaneous (SQ)
Ozempic,Metabolic,semaglutide,Obesity,Subcutaneous (SQ)
Padcev,Oncology,enfortumab vedotin-ejfv,Solid Tumors,Intravenous (IV)
Padcev,Oncology,enfortumab vedotin-ejfv,Bladder Cancer,Intravenous (IV)
Parsabiv,Endocrine,velcalcetide,Hyperparathyroidism (Secondary),Intravenous (IV)
Perseris,Psychiatry,risperidone,Schizophrenia,Subcutaneous (SQ)
Plavix,Hematology,clopidogrel bisulfate,Stroke Prevention in Atrial Fibrillation (SPAF),Oral (PO)
Plavix,Neurology,clopidogrel bisulfate,Ischemic Stroke,Oral (PO)
Plavix,Cardiovascular,clopidogrel bisulfate,Peripheral Arterial Disease (PAD),Oral (PO)
Plavix,Cardiovascular,clopidogrel bisulfate,Acute Coronary Syndrome (ACS),Oral (PO)
Plavix,Cardiovascular,clopidogrel bisulfate,Cardiovascular Disease,Oral (PO)
Plavix,Cardiovascular,clopidogrel bisulfate,Percutaneous Coronary Interventions (PCIs) for Stable Angina,Oral (PO)
Plegridy,Neurology,peginterferon beta-1a,Multiple Sclerosis (MS),"Intramuscular (IM), Subcutaneous (SQ)"
Poteligeo,Allergy,mogamulizumab-kpkc,Allergic Rhinitis,Intravenous (IV)
Poteligeo,Oncology,mogamulizumab-kpkc,Peripheral T-Cell Lymphoma (PTCL) - NHL,Intravenous (IV)
Poteligeo,Respiratory,mogamulizumab-kpkc,Asthma,Intravenous (IV)
Poteligeo,Oncology,mogamulizumab-kpkc,Cutaneous T-Cell Lymphoma (CTCL) - NHL,Intravenous (IV)
Poteligeo,Oncology,mogamulizumab-kpkc,Adult T-cell Leukemia/Lymphoma (ATL),Intravenous (IV)
Poteligeo,Oncology,mogamulizumab-kpkc,Solid Tumors,Intravenous (IV)
Poteligeo,Oncology,mogamulizumab-kpkc,Non-Small Cell Lung Cancer (NSCLC),Intravenous (IV)
Poteligeo,Autoimmune/immunology,mogamulizumab-kpkc,Inflammatory Disorders,Intravenous (IV)
Procrit,Cardiovascular,epoetin alfa,Acute Coronary Syndrome (ACS),"Intravenous (IV), Subcutaneous (SQ)"
Procrit,Oncology,epoetin alfa,Myelodysplastic Syndrome (MDS),"Intravenous (IV), Subcutaneous (SQ)"
Procrit,Hematology,epoetin alfa,Anemia,"Intravenous (IV), Subcutaneous (SQ)"
Procrit,Neurology,epoetin alfa,Ischemic Stroke,"Intravenous (IV), Subcutaneous (SQ)"
Procrit,Hematology,epoetin alfa,Anemia Related to HIV / AIDS,"Intravenous (IV), Subcutaneous (SQ)"
Procrit,Hematology,epoetin alfa,"Anemia Due to Chronic Renal Failure, Dialysis-Independent","Intravenous (IV), Subcutaneous (SQ)"
Procrit,Hematology,epoetin alfa,"Anemia Due to Chronic Renal Failure, Dialysis-Dependent","Intravenous (IV), Subcutaneous (SQ)"
Procrit,Hematology,epoetin alfa,Anemia Due to Oncology Treatment,"Intravenous (IV), Subcutaneous (SQ)"
Promacta,Autoimmune/immunology,eltrombopag olamine,Immune Thrombocytopenic Purpura (ITP),Oral (PO)
Promacta,Hematology,eltrombopag olamine,Thrombocytopenia,Oral (PO)
Promacta,Oncology,eltrombopag olamine,Sarcoma,Oral (PO)
Promacta,Oncology,eltrombopag olamine,Acute Myelogenous Leukemia (AML),Oral (PO)
Promacta,Hematology,eltrombopag olamine,Aplastic Anemia,Oral (PO)
Promacta,Oncology,eltrombopag olamine,Myelodysplastic Syndrome (MDS),Oral (PO)
Promacta,Not Specified,eltrombopag olamine,Acute Radiation Syndrome (ARS),Oral (PO)
Qbrexza,Dermatology,glycopyrronium tosylate,Dermatology,Topical
Rapaflo,Urology,silodosin,Benign Prostatic Hyperplasia (BPH),Oral (PO)
Rebif,Neurology,interferon beta-1a,Multiple Sclerosis (MS),Subcutaneous (SQ)
Rebif,Infectious Disease,interferon beta-1a,Hepatitis C (HCV) (Antiviral),Subcutaneous (SQ)
Rebif,Infectious Disease,interferon beta-1a,COVID-19 Treatment,Subcutaneous (SQ)
Relistor IV,Gastroenterology (Non Inflammatory Bowel Disease),methylnaltrexone,Postoperative Ileus,Intravenous (IV)
Remodulin (Injection),Cardiovascular,treprostinil sodium,Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH),"Intravenous (IV), Subcutaneous (SQ)"
Remodulin (Injection),Cardiovascular,treprostinil sodium,Peripheral Arterial Disease (PAD),"Intravenous (IV), Subcutaneous (SQ)"
Retacrit,Hematology,epoetin zeta,"Anemia Due to Chronic Renal Failure, Dialysis-Dependent","Intravenous (IV), Subcutaneous (SQ)"
Retacrit,Hematology,epoetin zeta,"Anemia Due to Chronic Renal Failure, Dialysis-Independent","Intravenous (IV), Subcutaneous (SQ)"
Retacrit,Hematology,epoetin zeta,Anemia Due to Oncology Treatment,"Intravenous (IV), Subcutaneous (SQ)"
Rexulti,Psychiatry,brexpiprazole,Post-Traumatic Stress Disorder (PTSD),"Intramuscular (IM), Oral (PO), Subcutaneous (SQ)"
Rexulti,Neurology,brexpiprazole,Neurology - Other,"Intramuscular (IM), Oral (PO), Subcutaneous (SQ)"
Rexulti,Psychiatry,brexpiprazole,Bipolar Disorder,"Intramuscular (IM), Oral (PO), Subcutaneous (SQ)"
Rexulti,Neurology,brexpiprazole,Alzheimer's Disease (AD),"Intramuscular (IM), Oral (PO), Subcutaneous (SQ)"
Rexulti,Psychiatry,brexpiprazole,Major Depressive Disorder (MDD),"Intramuscular (IM), Oral (PO), Subcutaneous (SQ)"
Rexulti,Psychiatry,brexpiprazole,Schizophrenia,"Intramuscular (IM), Oral (PO), Subcutaneous (SQ)"
Rexulti,Psychiatry,brexpiprazole,Attention Deficit Hyperactivity Disorder (ADHD),"Intramuscular (IM), Oral (PO), Subcutaneous (SQ)"
Reyvow,Neurology,lasmiditan,Migraine and Other Headaches,Oral (PO)
Risperdal,Psychiatry,risperidone,Antipsychotics - Revenue From Other Indications,Oral (PO)
Risperdal,Psychiatry,risperidone,Schizophrenia,Oral (PO)
Risperdal,Neurology,risperidone,Autism Spectrum Disorders (Autism),Oral (PO)
Risperdal,Neurology,risperidone,Alzheimer's Disease (AD),Oral (PO)
Risperdal,Psychiatry,risperidone,Bipolar Disorder,Oral (PO)
Risperdal Consta,Psychiatry,risperidone,Schizophrenia,Intramuscular (IM)
Risperdal Consta,Psychiatry,risperidone,Bipolar Disorder,Intramuscular (IM)
Rozerem,Neurology,ramelteon,Insomnia,Oral (PO)
Rozerem,Psychiatry,ramelteon,Bipolar Disorder,Oral (PO)
Rukobia,Infectious Disease,fostemsavir,HIV / AIDS,Oral (PO)
Rybelsus,Endocrine,semaglutide,"Diabetes Mellitus, Type II",Oral (PO)
Rybelsus,Neurology,semaglutide,Alzheimer's Disease (AD),Oral (PO)
Rybelsus,Cardiovascular,semaglutide,Cardiovascular Disease,Oral (PO)
Saizen,Endocrine,somatropin,Short Stature / Growth Hormone Deficiency,"Intramuscular (IM), Subcutaneous (SQ)"
Samsca,Endocrine,tolvaptan,Hyponatremia,Oral (PO)
Samsca,Cardiovascular,tolvaptan,Acute Decompensated Heart Failure,Oral (PO)
Samsca,Gastroenterology (Non Inflammatory Bowel Disease),tolvaptan,Liver Failure / Cirrhosis,Oral (PO)
Samsca,Renal,tolvaptan,Polycystic Kidney Disease,Oral (PO)
Sandostatin,Endocrine,octreotide acetate,Acromegaly,"Intravenous (IV), Subcutaneous (SQ)"
Sandostatin,Oncology,octreotide acetate,Neuroendocrine Tumors (NET),"Intravenous (IV), Subcutaneous (SQ)"
Sandostatin,Endocrine,octreotide acetate,Hyperinsulinemia/Hypoglycemia,"Intravenous (IV), Subcutaneous (SQ)"
Saxenda,Metabolic,liraglutide recombinant,Obesity,Subcutaneous (SQ)
Seebri Neohaler,Respiratory,glycopyrronium bromide,Asthma,Inhaled
Seebri Neohaler,Respiratory,glycopyrronium bromide,Chronic Obstructive Pulmonary Disease (COPD),Inhaled
Selzentry,Autoimmune/immunology,maraviroc,Rheumatoid Arthritis (RA),"Oral (PO), Rectal, Intravaginal"
Selzentry,Infectious Disease,maraviroc,HIV / AIDS,"Oral (PO), Rectal, Intravaginal"
Sensipar,Endocrine,cinacalcet hydrochloride,Hyperparathyroidism (Secondary),Oral (PO)
Sensipar,Endocrine,cinacalcet hydrochloride,Hyperparathyroidism (Primary),Oral (PO)
Seroquel,Psychiatry,quetiapine fumarate,Bipolar Disorder,Oral (PO)
Seroquel,Psychiatry,quetiapine fumarate,Schizophrenia,Oral (PO)
Seroquel,Psychiatry,quetiapine fumarate,Major Depressive Disorder (MDD),Oral (PO)
Seroquel,Neurology,quetiapine fumarate,Dementia,Oral (PO)
Seroquel,Psychiatry,quetiapine fumarate,Antipsychotics - Revenue From Other Indications,Oral (PO)
Singulair,Respiratory,montelukast sodium,Asthma,Oral (PO)
Singulair,Allergy,montelukast sodium,Allergic Rhinitis,Oral (PO)
Somatuline Autogel,Endocrine,lanreotide acetate,Acromegaly,Subcutaneous (SQ)
Somatuline Autogel,Oncology,lanreotide acetate,Neuroendocrine Tumors (NET),Subcutaneous (SQ)
Somatuline Autogel,Oncology,lanreotide acetate,Prostate Cancer,Subcutaneous (SQ)
Somatuline Autogel,Ophthalmology,lanreotide acetate,Thyroid Eye Disease (TED),Subcutaneous (SQ)
Somavert,Endocrine,pegvisomant,Acromegaly,Subcutaneous (SQ)
Synagis,Infectious Disease,palivizumab,Respiratory Syncytial Virus (RSV) Prevention,Intramuscular (IM)
Taptiqom,Ophthalmology,tafluprost/timolol maleate,Glaucoma / Ocular Hypertension (Ophthalmology),Topical
Timoptic,Ophthalmology,timolol maleate,Glaucoma / Ocular Hypertension (Ophthalmology),Topical
Toprol-XL,Cardiovascular,metoprolol succinate,Hypertension (Systemic),Oral (PO)
Toprol-XL,Cardiovascular,metoprolol succinate,Congestive Heart Failure (CHF) and Cardiomyopathies,Oral (PO)
Toviaz,Urology,fesoterodine,Overactive Bladder (OAB),Oral (PO)
Trelstar,Obstetrics/Gynecology,triptorelin pamoate,Endometriosis,"Intramuscular (IM), Subcutaneous (SQ)"
Trelstar,Oncology,triptorelin pamoate,Breast Cancer,"Intramuscular (IM), Subcutaneous (SQ)"
Trelstar,Oncology,triptorelin pamoate,Prostate Cancer,"Intramuscular (IM), Subcutaneous (SQ)"
Trelstar,Oncology,triptorelin pamoate,Head and Neck Cancer,"Intramuscular (IM), Subcutaneous (SQ)"
Trintellix,Psychiatry,vortioxetine,Attention Deficit Hyperactivity Disorder (ADHD),Oral (PO)
Trintellix,Psychiatry,vortioxetine,Generalized Anxiety Disorder (GAD),Oral (PO)
Trintellix,Psychiatry,vortioxetine,Major Depressive Disorder (MDD),Oral (PO)
Trulicity,Endocrine,dulaglutide,"Diabetes Mellitus, Type II",Subcutaneous (SQ)
Trulicity,Cardiovascular,dulaglutide,Cardiovascular Disease,Subcutaneous (SQ)
Tysabri,Neurology,natalizumab,Seizure Disorders (Epilepsy),Intravenous (IV)
Tysabri,Autoimmune/immunology,natalizumab,Graft vs. Host Disease (GVHD) - Treatment,Intravenous (IV)
Tysabri,Autoimmune/immunology,natalizumab,Ulcerative Colitis (UC),Intravenous (IV)
Tysabri,Oncology,natalizumab,Multiple Myeloma (MM),Intravenous (IV)
Tysabri,Neurology,natalizumab,Ischemic Stroke,Intravenous (IV)
Tysabri,Neurology,natalizumab,Multiple Sclerosis (MS),Intravenous (IV)
Tysabri,Autoimmune/immunology,natalizumab,Crohn's Disease,Intravenous (IV)
Tysabri,Autoimmune/immunology,natalizumab,Rheumatoid Arthritis (RA),Intravenous (IV)
Ubrelvy,Neurology,ubrogepant,Migraine and Other Headaches,Oral (PO)
Uptravi,Cardiovascular,selexipag,Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH),Oral (PO)
Uptravi,Cardiovascular,selexipag,Raynaud's Phenomenon,Oral (PO)
Ventolin,Respiratory,albuterol,Asthma,"Inhaled, Oral (PO)"
Ventolin,Respiratory,albuterol,Chronic Obstructive Pulmonary Disease (COPD),"Inhaled, Oral (PO)"
VESIcare,Urology,solifenacin succinate,Overactive Bladder (OAB),Oral (PO)
Viberzi,Gastroenterology (Non Inflammatory Bowel Disease),eluxadoline,Irritable Bowel Syndrome (IBS),Oral (PO)
Victoza,Endocrine,liraglutide recombinant,"Diabetes Mellitus, Type I",Subcutaneous (SQ)
Victoza,Endocrine,liraglutide recombinant,"Diabetes Mellitus, Type II",Subcutaneous (SQ)
Victoza,Endocrine,liraglutide recombinant,Prader-Willi Syndrome,Subcutaneous (SQ)
Victoza,Cardiovascular,liraglutide recombinant,Congestive Heart Failure (CHF) and Cardiomyopathies,Subcutaneous (SQ)
Victoza,Endocrine,liraglutide recombinant,Non-Alcoholic Steatohepatitis (NASH),Subcutaneous (SQ)
Victoza,Cardiovascular,liraglutide recombinant,Cardiovascular Disease,Subcutaneous (SQ)
Victoza,Neurology,liraglutide recombinant,Alzheimer's Disease (AD),Subcutaneous (SQ)
Vraylar,Psychiatry,cariprazine hydrochloride,Schizophrenia,Oral (PO)
Vraylar,Psychiatry,cariprazine hydrochloride,Bipolar Disorder,Oral (PO)
Vraylar,Psychiatry,cariprazine hydrochloride,Major Depressive Disorder (MDD),Oral (PO)
Vyleesi,Cardiovascular,bremelanotide,Hypovolemia,Subcutaneous (SQ)
Vyleesi,Urology,bremelanotide,Erectile Dysfunction (ED),Subcutaneous (SQ)
Vyleesi,Obstetrics/Gynecology,bremelanotide,Female Sexual Arousal Disorder,Subcutaneous (SQ)
Xalatan,Ophthalmology,latanoprost,Glaucoma / Ocular Hypertension (Ophthalmology),Topical
Xiidra,Ophthalmology,lifitegrast,Allergic Conjunctivitis (Ophthalmology),Topical
Xiidra,Ophthalmology,lifitegrast,Dry Eye (Ophthalmology),Topical
Xywav,Neurology,sodium oxybate,Narcolepsy,Oral (PO)
Yervoy,Oncology,ipilimumab,Hematologic Cancer,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Colorectal Cancer (CRC),Intravenous (IV)
Yervoy,Oncology,ipilimumab,Myelodysplastic Syndrome (MDS),Intravenous (IV)
Yervoy,Oncology,ipilimumab,Uveal Melanoma,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Solid Tumors,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Merkel Cell Carcinoma,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases),Intravenous (IV)
Yervoy,Oncology,ipilimumab,Mesothelioma,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Bladder Cancer,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Esophageal Cancer,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Head and Neck Cancer,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Small Cell Lung Cancer (SCLC),Intravenous (IV)
Yervoy,Oncology,ipilimumab,Gastric Cancer,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Ovarian Cancer,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Pancreatic Cancer,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Indolent Non-Hodgkin's Lymphoma (Including Follicular Lymphoma) - NHL,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Non-Small Cell Lung Cancer (NSCLC),Intravenous (IV)
Yervoy,Oncology,ipilimumab,Breast Cancer,Intravenous (IV)
Yervoy,Infectious Disease,ipilimumab,HIV / AIDS,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Renal Cell Cancer (RCC),Intravenous (IV)
Yervoy,Oncology,ipilimumab,Prostate Cancer,Intravenous (IV)
Yervoy,Oncology,ipilimumab,Melanoma,Intravenous (IV)
Zebeta,Cardiovascular,bisoprolol fumarate,Congestive Heart Failure (CHF) and Cardiomyopathies,Oral (PO)
Zebeta,Cardiovascular,bisoprolol fumarate,Hypertension (Systemic),Oral (PO)
Zebeta,Cardiovascular,bisoprolol fumarate,Angina,Oral (PO)
Zebeta,Cardiovascular,bisoprolol fumarate,Atrial Fibrillation/Flutter,Oral (PO)
Zetia,Cardiovascular,ezetimibe,Dyslipidemia / Hypercholesterolemia,Oral (PO)
Zioptan,Ophthalmology,tafluprost,Glaucoma / Ocular Hypertension (Ophthalmology),Intraocular/Subretinal/Subconjunctival
Zoladex,Oncology,goserelin acetate,Breast Cancer,Subcutaneous (SQ)
Zoladex,Oncology,goserelin acetate,Prostate Cancer,Subcutaneous (SQ)
Zoladex,Obstetrics/Gynecology,goserelin acetate,Endometriosis,Subcutaneous (SQ)
Zyprexa (Oral and IM),Psychiatry,olanzapine,Bipolar Disorder,"Intramuscular (IM), Oral (PO)"
Zyprexa (Oral and IM),Psychiatry,olanzapine,Schizophrenia,"Intramuscular (IM), Oral (PO)"
Zyprexa (Oral and IM),Psychiatry,olanzapine,Major Depressive Disorder (MDD),"Intramuscular (IM), Oral (PO)"
Zyprexa (Oral and IM),Psychiatry,olanzapine,Antipsychotics - Revenue From Other Indications,"Intramuscular (IM), Oral (PO)"